In failing hearts or catecholaminergic polymorphic ventricular tachycardia (CPVT), RyR2 sensitivity to Mg2+ inhibition is decreased, promoting arrhythmogenic Ca2+ release [76,83]. This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia.